Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
learning, with access to VIB’s personal and professional development programs. How to apply? Motivated candidates can apply via the online VIB application form (https://jobs.vib.be/apply/132752
-
package based on expertise and experience At SWITCH we have particular attention for the career development goals of our people and actively support the ambitions of our lab members in the lab and beyond
-
development. Competitive salary and benefits. Full‑time, indefinite contract with flexible working arrangements. How to apply Apply via the online application tool (https://jobs.vib.be/apply/132489 ). Include
-
Chart tumour evolution using cutting-edge long-read and single-cell multiomics Who we are The Integrative Cancer Genomics lab (Jonas Demeulemeester) is embedded within the VIB – KU Leuven Center
-
homeostasis to disease. About the role We are seeking a motivated software developer who wants to join the Saeys lab within the VIB-UGent Center for Inflammation Research to help develop, maintain and extend
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
Leuven, Belgium and is part of the VIB-KU Leuven Center for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative
-
leading research institute focused on understanding cancer biology and developing innovative therapies. Our Bioinformatics & AI Expertise Unit provides advanced computational support to multiple research
-
, concepts, formats, scripts, visuals, subtitles, and workflow. You experiment (and learn) with tools to produce faster and better, without losing the brand style. Content planning and monitoring You develop
-
for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative disease. They are also conducting advanced CRISPR screens